tiprankstipranks
Galectin Therapeutics Inc (GALT)
NASDAQ:GALT
Holding GALT?
Track your performance easily

Galectin Therapeutics (GALT) Ownership - Who Owns Galectin Therapeutics?

565 Followers

Galectin Therapeutics (GALT) Ownership Overview

27.87%4.59%5.68%4.46%57.40%
27.87% Insiders
5.68% Other Institutional Investors
4.46% ETFs
57.40% Public Companies and
Individual Investors
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail, and individual investors. Approximately 14.73% of the company’s stock is owned by Institutional Investors, 27.87% is owned by Insiders, and 57.40% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 23, 2024
Kary Eldred
Director
xxxxxxxxxxxxx
$1300
Oct 17, 2024
xxxxxxxxxxxxx
$3432
Oct 16, 2024
xxxxxxxxxxxxx
$27000
Aug 26, 2024
xxxxxxxxxxxxx
$8050

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,296,461Insider16.41%28,984,538
5,922,207Insider9.44%16,671,013
2,028,390Institution3.23%5,709,918
1,917,722Institution3.06%5,398,387
899,012Insider1.43%2,530,719
626,659Institution1.00%1,764,045
482,923Institution0.77%1,359,428
202,383Institution0.32%569,708
132,832Insider0.21%373,922
99,231Institution0.16%279,335

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,917,722Institution3.06%5,398,387
482,923Institution0.77%1,359,428
202,383Institution0.32%569,708
99,231Institution0.16%279,335
65,073Institution0.10%183,180
37,318Institution0.06%105,050
27,623Institution0.04%77,759
26,902Institution0.04%75,729
9,489Institution0.02%26,712
5,516Institution<0.01%15,528

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,247,562Institution1.99%3,081,478
670,160Institution1.07%1,655,295
393,581Institution0.63%1,107,931
108,241Institution0.17%304,698
92,754Institution0.15%229,102
74,850Institution0.12%210,703
75,954Institution0.12%208,874
51,484Institution0.08%141,838
46,927Institution0.07%132,100
11,124Institution0.02%30,647

FAQ

Who Owns Galectin Therapeutics Inc (GALT)?
According to the latest TipRanks data, approximately 5.68% of the company's stock is held by institutional investors, 27.87% is held by insiders, and 57.40% is held by retail investors.
    What percentage of Galectin Therapeutics Inc (GALT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 5.68% of Galectin Therapeutics Inc (GALT) stock is held by institutional investors.
      What percentage of Galectin Therapeutics Inc (GALT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 57.40% of Galectin Therapeutics Inc (GALT) stock is held by retail investors.
        Who owns the most shares of Galectin Therapeutics Inc (GALT)?
        Richard E Uihlein owns the most shares of Galectin Therapeutics Inc (GALT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis